CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-15 | Higgons John Duncan Chief Operating Officer | Sale | −20,000 | $50.09 | $1.0M | 61,835 |
| 2015-12-03 | Schenkein David P Chief Executive Officer | Grant or award · Stock option (right to buy) | +68,181 | 935,501 | ||
| 2015-12-03 | Higgons John Duncan Chief Operating Officer | Grant or award · Stock option (right to buy) | +34,090 | 239,112 | ||
| 2015-12-03 | Biller Scott Chief Scientific Officer | Grant or award · Stock option (right to buy) | +34,091 | 313,971 | ||
| 2015-11-30 | Biller Scott Chief Scientific Officer | Exercise or conversion | +5,500 | $31.64 | $174K | 39,570 |
| 2015-11-30 | Biller Scott Chief Scientific Officer | Sale | −5,500 | $65.99 | $363K | 34,070 |
| 2015-11-30 | Biller Scott Chief Scientific Officer | Exercise or conversion · Stock option (right to buy) | −5,500 | 279,880 | ||
| 2015-11-17 | Cantley Lewis Clayton Jr. Director | Sale | −3,490 | $59.99 | $209K | 138,150 |
| 2015-11-17 | Cantley Lewis Clayton Jr. Director | Sale | −3,492 | $59.98 | $209K | 138,150 |
| 2015-11-17 | Cantley Lewis Clayton Jr. Director | Sale | −3,490 | $59.99 | $209K | 138,299 |
| 2015-11-17 | Cantley Lewis Clayton Jr. Director | Sale | −3,492 | $59.98 | $209K | 138,297 |
| 2015-11-16 | Cantley Lewis Clayton Jr. Director | Sale | −1,362 | $59.59 | $81K | 141,640 |
| 2015-11-16 | Cantley Lewis Clayton Jr. Director | Sale | −1,360 | $59.58 | $81K | 141,642 |
| 2015-11-16 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +10,909 | $0.47 | $5K | 92,744 |
| 2015-11-16 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +2,479 | $0.47 | $1K | 95,223 |
| 2015-11-16 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +6,612 | $2.34 | $15K | 101,835 |
| 2015-11-16 | Higgons John Duncan Chief Operating Officer | Sale | −20,000 | $61.51 | $1.2M | 81,835 |
| 2015-11-16 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −10,909 | 214,113 | ||
| 2015-11-16 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −2,479 | 211,634 | ||
| 2015-11-16 | Higgons John Duncan Chief Operating Officer | Exercise or conversion · Stock option (right to buy) | −6,612 | 205,022 |
Page 84 of 93 · 1,853 trades